Glucosamine and/or chondroitin versus structural modulation of gut microbiota: friend or FOE?
| dc.contributor.author | Rekalov, D. | |
| dc.contributor.author | Golovach, I. | |
| dc.contributor.author | Mefford, T. | |
| dc.contributor.author | Tarasenko, T. | |
| dc.contributor.author | Bryner, I. | |
| dc.contributor.author | Daniuk, I. | |
| dc.contributor.author | Dotsenko, S. | |
| dc.contributor.author | Доценко, Сергій Якович | |
| dc.date.accessioned | 2025-05-13T07:46:06Z | |
| dc.date.available | 2025-05-13T07:46:06Z | |
| dc.date.issued | 2024 | |
| dc.identifier.citation | Glucosamine and/or chondroitin versus structural modulation of gut microbiota: friend or FOE? / D. Rekalov, I. Golovach, T. Mefford, T. Tarasenko, I. Bryner, I. Daniuk, S. Dotsenko // Aging Clinical and Experimental Research : Plenary Lectures Abstr. of World Congr. on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2024). - 2024. - Art. P588. | uk_UK |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/22562 | |
| dc.language.iso | en | uk_UK |
| dc.subject | тези доповідей | uk_UK |
| dc.title | Glucosamine and/or chondroitin versus structural modulation of gut microbiota: friend or FOE? | uk_UK |
| dc.type | Other | uk_UK |